
Mridul Dhanuka
About Mridul Dhanuka
Data last updated:
Mridul Dhanuka is a Director at Dhanuka Laboratories Limited (since 2005), Whole-Time Director at Orchid Pharma Limited (since 2020) and Director at Orbion Pharmaceuticals Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Real Estate and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹2,553 Cr; the largest is Dhanuka Laboratories Limited at ₹1,424 Cr (FY 2025). Earlier, Mridul Dhanuka was a Partner at Altacura Ai Absolute Return Fund Llp (2024–2025) and Director at Dhanuka Agritech Limited (2011–2023) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Oct 2005 | 1993 | ₹1,424 Cr (FY 2025) | Active | |
| Whole-Time Director | 31 Mar 2020 | 1992 | ₹949 Cr (FY 2025) | Active | |
| Director | 31 May 2021 | 2021 | ₹179 Cr (FY 2025) | Active | |
| Director | 24 Mar 2022 | 2022 | ₹43.3 Lakh (FY 2025) | Active | |
| Director | 20 Apr 2005 | 2005 | ₹1.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 29 Feb 2024 | 2021 | ₹111 Cr (FY 2024) | Active | |
| Director | 23 May 2011 | 1985 | ₹2,071 Cr (FY 2025) | Active | |
| Director | 16 Dec 2009 | 1985 | ₹120 Cr (FY 2024) | Active | |
| Director | 17 Dec 2009 | 1984 | ₹4.89 Cr (FY 2022) | Active | |
| Director | 02 Jan 2006 | 2006 | ₹1,014 Cr (FY 2025) | Active | |
| Director | 21 Jun 2021 | 2021 | Strike Off | ||
| Director | 04 Sep 2010 | 2006 | Strike Off | ||
| Whole-Time Director | 15 Mar 2007 | 1960 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mridul Dhanuka
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mridul Dhanuka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mridul Dhanuka
Mridul Dhanuka currently holds 5 directorships: Dhanuka Laboratories Limited (Director, since 06 Oct 2005, revenue ₹1,424 Cr (FY 2025)); Orchid Pharma Limited (Whole-Time Director, since 31 Mar 2020, revenue ₹949 Cr (FY 2025)); Orbion Pharmaceuticals Private Limited (Director, since 31 May 2021, revenue ₹179 Cr (FY 2025)); Orchid Bio-Pharma Limited (Director, since 24 Mar 2022, revenue ₹43.3 Lakh (FY 2025)); M D Buildtech Private Limited (Director, since 20 Apr 2005, revenue ₹1.1 Lakh (FY 2025)).
Mridul Dhanuka was first appointed on 20 Apr 2005 as Director at M D Buildtech Private Limited. The most recent appointment on record is 29 Feb 2024 at Altacura Ai Absolute Return Fund Llp.
The 5 current companies of Mridul Dhanuka that report revenue have a combined latest revenue of ₹2,553 Cr: Dhanuka Laboratories Limited ₹1,424 Cr (FY 2025); Orchid Pharma Limited ₹949 Cr (FY 2025); Orbion Pharmaceuticals Private Limited ₹179 Cr (FY 2025); Orchid Bio-Pharma Limited ₹43.3 Lakh (FY 2025); M D Buildtech Private Limited ₹1.1 Lakh (FY 2025).
Mridul Dhanuka held 8 earlier board appointments: Altacura Ai Absolute Return Fund Llp (Partner, 29 Feb 2024 to 31 Mar 2025); Dhanuka Agritech Limited (Director, 23 May 2011 to 07 Nov 2023); Hindon Mercantile Limited (Director, 16 Dec 2009 to 25 Mar 2011); Exclusive Leasing And Finance Private Limited (Director, 17 Dec 2009 to 23 May 2011); Otsuka Chemical (India) Private Limited (Director, 02 Jan 2006 to 25 Sep 2019); and 3 more.
The current boards of Mridul Dhanuka's companies include Arjun Dhanuka (Dhanuka Laboratories Limited), Mahendra Kumar Dhanuka (Dhanuka Laboratories Limited), Manish Dhanuka (Dhanuka Laboratories Limited), Pramod Kumar Singh (Dhanuka Laboratories Limited), Preeti (Dhanuka Laboratories Limited), Rahul Dhanuka (Dhanuka Laboratories Limited), among others.